BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 30730781)

  • 21. Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study.
    Armstrong GT; Liu Q; Yasui Y; Huang S; Ness KK; Leisenring W; Hudson MM; Donaldson SS; King AA; Stovall M; Krull KR; Robison LL; Packer RJ
    J Natl Cancer Inst; 2009 Jul; 101(13):946-58. PubMed ID: 19535780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local control in non-metastatic medulloblastoma.
    Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
    Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the Childhood Cancer Survivor Study cohort.
    Mulrooney DA; Hyun G; Ness KK; Ehrhardt MJ; Yasui Y; Duprez D; Howell RM; Leisenring WM; Constine LS; Tonorezos E; Gibson TM; Robison LL; Oeffinger KC; Hudson MM; Armstrong GT
    BMJ; 2020 Jan; 368():l6794. PubMed ID: 31941657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What Are Risk Factors for and Outcomes of Late Amputation After Treatment for Lower Extremity Sarcoma: A Childhood Cancer Survivor Study Report.
    Geiger EJ; Liu W; Srivastava DK; Bernthal NM; Weil BR; Yasui Y; Ness KK; Krull KR; Goldsby RE; Oeffinger KC; Robison LL; Dieffenbach BV; Weldon CB; Gebhardt MC; Howell R; Murphy AJ; Leisenring WM; Armstrong GT; Chow EJ; Wustrack RL
    Clin Orthop Relat Res; 2023 Mar; 481(3):526-538. PubMed ID: 35583517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early aging in adult survivors of childhood medulloblastoma: long-term neurocognitive, functional, and physical outcomes.
    Edelstein K; Spiegler BJ; Fung S; Panzarella T; Mabbott DJ; Jewitt N; D'Agostino NM; Mason WP; Bouffet E; Tabori U; Laperriere N; Hodgson DC
    Neuro Oncol; 2011 May; 13(5):536-45. PubMed ID: 21367970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
    Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB
    Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Modifiable Health Conditions and Social Determinants of Health With Late Mortality in Survivors of Childhood Cancer.
    Ehrhardt MJ; Liu Q; Dixon SB; Caron E; Redd D; Shelton K; Huang IC; Bhakta N; Ness KK; Mulrooney DA; Brinkman TM; Chemaitilly W; Delaney A; Armstrong GT; Srivastava DK; Zaidi A; Robison LL; Yasui Y; Hudson MM
    JAMA Netw Open; 2023 Feb; 6(2):e2255395. PubMed ID: 36763361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal changes in treatment and late mortality and morbidity in adult survivors of childhood glioma: a report from the Childhood Cancer Survivor Study.
    de Blank PMK; Lange KR; Xing M; Mirzaei Salehabadi S; Srivastava D; Brinkman TM; Ness KK; Oeffinger KC; Neglia J; Krull KR; Nathan PC; Howell R; Turcotte LM; Leisenring W; Armstrong GT; Okcu MF; Bowers DC
    Nat Cancer; 2024 Apr; 5(4):590-600. PubMed ID: 38429413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medulloblastoma has a global impact on health related quality of life: Findings from an international cohort.
    de Medeiros CB; Moxon-Emre I; Scantlebury N; Malkin D; Ramaswamy V; Decker A; Law N; Kumabe T; Leonard J; Rubin J; Jung S; Kim SK; Gupta N; Weiss W; Faria CC; Vibhakar R; Lafay-Cousin L; Chan J; Kros JM; Janzen L; Taylor MD; Bouffet E; Mabbott DJ
    Cancer Med; 2020 Jan; 9(2):447-459. PubMed ID: 31755223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
    Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
    Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy and Response Directed High Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy).
    Vivekanandan S; Breene R; Ramanujachar R; Traunecker H; Pizer B; Gaze MN; Saran F; Thorp N; English M; Wheeler KA; Michalski A; Walker DA; Saunders D; Cowie F; Cameron A; Picton SV; Parashar D; Horan G; Williams MV
    Pediatr Blood Cancer; 2015 Dec; 62(12):2132-9. PubMed ID: 26274622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
    Yock TI; Yeap BY; Ebb DH; Weyman E; Eaton BR; Sherry NA; Jones RM; MacDonald SM; Pulsifer MB; Lavally B; Abrams AN; Huang MS; Marcus KJ; Tarbell NJ
    Lancet Oncol; 2016 Mar; 17(3):287-298. PubMed ID: 26830377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic role of chemotherapy, radiotherapy dose, and extent of surgical resection in adult medulloblastoma.
    Haque W; Verma V; Brian Butler E; Teh BS
    J Clin Neurosci; 2020 Jun; 76():154-160. PubMed ID: 32291240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.
    Turcotte LM; Whitton JA; Friedman DL; Hammond S; Armstrong GT; Leisenring W; Robison LL; Neglia JP
    J Clin Oncol; 2015 Nov; 33(31):3568-75. PubMed ID: 26261260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Childhood medulloblastoma-a single institution's historical perspective on survival and functional morbidity.
    Phipps K; Kirkman MA; Aquilina K; Gaze M; Michalski A; Wade A; Hayward R
    Childs Nerv Syst; 2019 Dec; 35(12):2327-2338. PubMed ID: 31686139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study.
    Hill RM; Richardson S; Schwalbe EC; Hicks D; Lindsey JC; Crosier S; Rafiee G; Grabovska Y; Wharton SB; Jacques TS; Michalski A; Joshi A; Pizer B; Williamson D; Bailey S; Clifford SC
    Lancet Child Adolesc Health; 2020 Dec; 4(12):865-874. PubMed ID: 33222802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Exercise With Mortality in Adult Survivors of Childhood Cancer.
    Scott JM; Li N; Liu Q; Yasui Y; Leisenring W; Nathan PC; Gibson T; Armenian SH; Nilsen TS; Oeffinger KC; Ness KK; Adams SC; Robison LL; Armstrong GT; Jones LW
    JAMA Oncol; 2018 Oct; 4(10):1352-1358. PubMed ID: 29862412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study.
    Wahba HA; Abu-Hegazy M; Wasel Y; Ismail EI; Zidan AS
    J BUON; 2013; 18(2):425-9. PubMed ID: 23818356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of and risk factors for late cholecystectomy in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.
    Dieffenbach BV; Li N; Madenci AL; Murphy AJ; Barnea D; Gibson TM; Tonorezos ES; Leisenring WM; Howell RM; Diller LR; Liu Q; Chow EJ; Armstrong GT; Yasui Y; Oeffinger KC; Weldon CB; Weil BR
    Eur J Cancer; 2020 Jul; 133():4-13. PubMed ID: 32422507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study.
    Oeffinger KC; Stratton KL; Hudson MM; Leisenring WM; Henderson TO; Howell RM; Wolden SL; Constine LS; Diller LR; Sklar CA; Nathan PC; Castellino SM; Barnea D; Smith SA; Hutchinson RJ; Armstrong GT; Robison LL
    J Clin Oncol; 2021 Jul; 39(20):2266-2275. PubMed ID: 33630659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.